IGF-1 (Insulin-like Growth Factor 1)
The anabolic signal that turns growth hormone into muscle repair
Plain English
IGF-1 (Insulin-like Growth Factor 1) is a peptide hormone produced primarily by the liver in response to growth hormone signaling. It mediates most of growth hormone's anabolic effects by activating the mTOR pathway inside muscle cells, driving protein synthesis and tissue repair. Sleep, protein, and resistance training all converge on this same signaling cascade.
The Mechanism
When the pituitary releases growth hormone (GH), the liver responds by producing IGF-1. This response is amplified by protein intake: leucine-rich protein after training provides the raw material that makes the IGF-1 signal productive. IGF-1 circulates to muscle tissue, binds to receptors on muscle cell membranes, and activates mTOR (mechanistic target of rapamycin), the primary molecular switch for muscle protein synthesis. It also stimulates satellite cells, which are the repair cells that fuse with damaged muscle fibers to facilitate recovery and growth.
Muscle tissue can also produce IGF-1 locally in response to mechanical loading, independent of circulating levels. This locally produced form responds directly to the mechanical stress of resistance training. It contributes to the muscle-specific hypertrophy response and may explain why trained muscles adapt even when systemic hormone levels are not elevated.
IGF-1 is elevated by adequate sleep (through the GH pulse that drives liver production), leucine-rich protein intake, resistance training, and healthy body composition. It is suppressed by caloric restriction, poor sleep, aging, and chronic stress. Because IGF-1 sits at the intersection of sleep quality, training stimulus, and protein nutrition, it is the biological reason these three variables are synergistic: each one activates or amplifies the same downstream pathway.
Why It Matters
Sleep, protein, and training all converge on the same anabolic pathway. IGF-1 is where they meet.
IGF-1 is why cutting sleep to train more is counterproductive. Without adequate deep sleep to drive GH and IGF-1 production, the muscle protein synthesis signal is suppressed even if training volume is high. Similarly, training without sufficient leucine-rich protein fails to give IGF-1 the substrate it needs to produce an anabolic result. The practical insight is that sleep, training, and protein are not independent variables you can trade off against each other; they are multiplicative.
Common Misconception
IGF-1 appears in cancer research because chronically elevated IGF-1, particularly from exogenous growth hormone administration, is associated with elevated risk in some populations. This causes some people to view any anabolic signaling with suspicion. The exercise-induced IGF-1 response is a different biological context entirely: it is acute, training-triggered, and self-limiting. Regular exercise is consistently associated with reduced cancer risk across the literature, not elevated risk.
Signs It Is Disrupted
- Stalled muscle development despite consistent training and adequate protein intake
- Extended soreness and recovery time between sessions
- Loss of lean mass during fat loss phases even with high protein intake
- Poor wound healing or slow soft tissue recovery
How to Improve It
3 Things to Remember
IGF-1 is the primary anabolic signal produced by the liver in response to growth hormone, and it activates muscle protein synthesis via the mTOR pathway.
Sleep, resistance training, and leucine-rich protein all converge on the same pathway; each amplifies the others rather than substituting for them.
The acute training-induced IGF-1 response is a normal, beneficial anabolic event and is distinct from the risks associated with chronic exogenous GH or IGF-1 administration.
Appears In
Related Terms
Protocol
Turn what you've learned into daily practice
Protocol pulls your wearable and nutrition data together into a daily health score, morning brief, and AI coaching. All in one place.
Get started free